Comparison of treatment completion rates with three short-course rifamycin-based regimens (three months of daily isoniazid plus rifampicin [3HR], three months of once-weekly isoniazid plus rifapentine [3HP], and four months of daily rifampicin [4R]) for treatment of latent tuberculosis infection in patients with end-stage kidney disease: A randomised controlled clinical trial]

• Código protocolo: PI21/004444
• Código EudraCT: 2021-003995-15
• Grupo de investigación: Neumología
• Servicio: Neumología
• Investigador/a principal:  De Souza Galvao, Maria Luiza
• Patología: Malalties del sistema respiratori
• Fase: Fase IV
• Estado: Reclutando voluntarios